Back to Selection     Print       Date : 31 Oct 2025
Fund Summary
ICICI Pru Pharma Healthcare And Diagnostics Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 13-Jul-18
Corpus(Cr.) 6437.0 Latest NAV 40.21 As on 05-12-2025
Equity(%) 97.07 52 Week High 41.47
Debt(%) 2.93 52 Week Low 33.8
Others(%) 0.0 Exit Load 1% for redemption within 15 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.87
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dharmesh Kakkad
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 44.03%
Top 10 Holdings 62.66%
Top 25 Holdings 87.37%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 84.55
Healthcare 6.38
Miscellaneous 3.08
Cash 2.93
Retail 1.23
Chemicals 1.17
Software & Services 0.66
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.16
PE Ratio 32.28
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 11.88
Dr Reddys Laboratories Limited 9.42
DIVI LABORATORIES LTD 8.50
Aurobindo Pharma Limited 7.62
Cipla Limited 6.61
Lupin Limited 5.40
Alkem Laboratories Limited 3.98
Biocon Limited 3.28
TREPS 3.18
Mankind Pharma Limited 2.79
Zydus Lifesciences Limited 2.67
Syngene International Limited 2.23
Cohance Lifesciences Limited 2.08
Thyrocare Technologies Limited 2.03
Medi Assist Healthcare Services Limited 1.91
ALEMBIC PHARMACEUTICALS 1.77
Gland Pharma Limited 1.72
J B Chemicals and Pharma Ltd 1.51
Pfizer Limited 1.46
Metropolis Healthcare Limited 1.34
WINDLAS BIOTEC LTD 1.26
MedPlus Health Services Limited 1.23
Star Health & Allied Insurance 1.17
EQ -FINE ORGANIC IND LTD 1.17
Anthem Biosciences Limited 1.16

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
0.25% 0.63% 3.50% 3.16%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.70% 6.00% 5.46% 7.43%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
24.24% 26.87% 18.60% 0.00%
 
 
13.19% 13.29% 15.94% 14.28%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 15.68% 1.3615 10.4319% 42.0839 0.1756
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 16.5438% 0.0002 0.3511 13.8690 1.2231
 
Back to Selection